Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 September 2020

MESSAGE FROM THE RECTOR AND VICE-CHANCELLOR: UPDATE ON DEVELOPMENTS AT THE UFS

I hope you are well, healthy, and safe. I have experienced an overwhelming sense of commitment from staff and students across the university to make a success of the 2020 academic year. Thank you for working together towards this common goal.

Currently, we have a significant number of students back on the campuses in line with the university’s reintegration plan, and others are continuing with online learning. On 16 September 2020, President Cyril Ramaphosa announced that the country will move to alert Level 1 as from midnight on Sunday 20 September 2020. During Level 1 of the national lockdown, we will continue to return staff and students in a structured and phased approach according to the university’s reintegration plan. However, we are still unable to return all our students to the campuses, as we have to adhere to physical distancing and hygiene measures and also have to take into account the capacity of the lecture venues on the campuses, but most specifically the residences.

Please note that you will be informed by your faculty if you are required to return to campus during Level 1. If you have NOT been contacted, you will be supported through remote multimodal teaching, learning, and assessment until you are informed by your faculty that you can return to campus.

Data shows that most of you have adapted well to the blended learning modes – I find it admirable and inspiring. Rest assured that your lecturers are continuing to work hard to deliver a quality teaching and learning experience. Please use the #LearnOn material as a guide to plan for the second semester and engage with your lecturers on academic problems or consult with your faculty structures to find suitable solutions.

The university is aware that international students who have been residing outside of the country during Levels 5 and 4, may return to campus during Level 1; we will communicate with these students in due course.

I am confident that you are focused and committed to completing the second semester. We have prepared a safe environment for students who are returning to campus during Level 1. Sufficient hygiene measures are in place, as well as re-configurations to ensure physical distancing. The wearing of masks, physical distancing, and hand sanitising remain compulsory on all the campuses.

During Level 1, campus access will remain restricted – only those with campus access permits will be allowed to enter. Space in our residences remains limited due to physical distancing and residence students must comply with the protocols in their respective residences. See the Return to campus of students_Level 1 of national lockdown document for more information.

Although our country will be on Level 1 of the national lockdown, it is still extremely important that you remain vigilant and take ownership of your health and look out for the health of those around you. Ultimately, your health is your responsibility. Please do not let your guard down and adhere to the protocols and regulations – for your own safety, and for the safety of others.

It is also important to keep your mental health in check – make use of the #WellbeingWarriors campaign from our Department of Student Counselling and Development, which is aimed at encouraging health and well-being among students. Visit the COVID-19 website for comprehensive information and updates.

Although the infection rate in our country is decreasing, remember that the COVID-19 pandemic is still testing every aspect of society; we must not underestimate the impact that the pandemic still has on local and global communities. Take care of yourselves and those around you and comply with the national guidelines and regulations.

I wish you all the best with your studies.

News Archive

Conference: Expanded ARV treatment
2005-03-02

VENUE: University of the Free State, Bloemfontein, South Africa
DATE: 30 March 2005 - 1 April 2005

  • ARV Programme as on 24Feb Download Word document
     
  • Programme Special events Download Word document


    Official web site www.fshealth.gov.za/subsites/arvc

     


    Rationale for the Conference
    At the time of the planned Conference, much ground would have been covered, both in the Free State and in South Africa, in respect of the expanded public sector ARV treatment programme in respect of research, experiences in practice, training of staff, treatment of patients, lessons learned, successes and failures, etc. The time would then be quite opportune to share these in a systematic manner with other provinces and countries, as well as with the large variety of stakeholders and role players in the ARV and related domains, be they academics and researchers, policy makers and service/facility managers, the variety of caregivers, and the community organisations and affected patients.

The Conference and current research
The proposed Conference is, firstly, directly linked to the current research on the public sector roll-out of ARV treatment in the Free State conducted by several research institutions (e.g. CIET, CHSR&D, UCT Lung Institute). Secondly, the Conference could and would serve as a forum for other research groups in the country and further a field to report and share knowledge and experiences on ARV treatment and related initiatives. Lastly, the Conference will stage a golden opportunity for researchers and scientists, on the one hand, and policy makers, managers, and caregivers (as knowledge users), on the other hand, to engage in cross-disciplinary discourse on this mutual and topical theme.

Theme of Conference
Expanded ARV treatment in the Free State: sharing experiences

Focus
The focus is primarily on public sector ARV treatment in the Free State, but also initiatives/activities/perspectives of relevance to the Free State elsewhere in the country at large and further a field, as well as relevant ARV initiatives in the public, private, NGO and FBO sectors. Bear in mind, however, that ARV treatment is but part of a much more comprehensive approach to HIV and AIDS. The Conference will, therefore, not narrowly focus on the ARV treatment programme only. The broader context, other relevant dimensions, and a comprehensive approach to the challenges of HIV, AIDS and TB are of equal importance.

The purpose of the Conference
Enhance meaningful exchange, mutual understanding and collaboration among researchers, scientists, policy makers, managers and practitioners in the field of ARV treatment and related fields.

Share experiences in the various spheres of ARV treatment and related spheres (policy, management, practice, research, training, public-private-civil society sectors).

Record, reflect and report on the establishment of the ARV treatment programme in the Free State, and in within the context of the comprehensive HIV/AIDS programme.

Disseminate important research results on ARV treatment and related themes to health policy makers, managers, practitioners, communities and to the research community.

Stimulate discourse among various disciplines and various stakeholders/role players involved in ARV treatment and related programmes.

Sensitise and acquaint researchers to the requirements of policy makers, managers and practitioners in respect of ARV treatment and related fields.

Facilitate the implementation of research results in ARV treatment policy, programmes and practice.

Dissemination of Conference-related information
Information generated during the Conference could feed into policy, management and practice of ARV treatment, the training accompanying such programme, and the existing body of knowledge. After the Conference the information will be disseminated via the Internet and by scientific and popular publications.

Date and duration
Set for 30 & 31 March & 1 April 2005; to commence at 09:00 on the first day (30 March) and to end at 16:30 (1 April) the third day.

Format and scope of Conference
Alternating plenary, parallel sessions and debates focused on topical issues and interest groups. The Conference will strive to be maximally interactive and participative.

Themes and topics to cover:

  • Policy, management and health services/practice (various levels and contexts – clinical treatment, information, IT systems, pharmacy, laboratories, nutrition)
     
  • Research covering all relevant disciplines and diverse dimensions of ARV treatment and related themes
  • Training and evaluation of training
  • Patients, communities and civil society organisations
  • Public, private, NGO, FBO initiatives and partnerships

Emphasis will be on the Free State, however, with of significant involvement from other provinces, SADC countries, and countries further a field. The thrust will be to export lessons and experiences from the Free State, but also to import lessons and experiences from other provinces, countries and sectors.

Presenters
Key presenters from the Free State, other provinces, South Africa, from the private, FBO and NGO sectors, and from several other countries

Delegates
About half of the delegates will be Free State stakeholders and role players (all levels and all contexts). The other half will be role players and stakeholders in the ARV and related fields from other provinces, the national level, and other countries, as well as from the private, public and non-governmental sectors.

Focused workshops
Provision will be made for half-a-day or one-day workshop initiatives on the third day (1 April 2005).

Enquiries
For more information please contact:

Prof Dingie van Rensburg
Centre for Health Systems Research & Development
University of the Free State
PO Box 339
Bloenfontein
SOUTH AFRICA
9300

Contact:
Carin van Vuuren
Conference Organiser
Centre for Health Systems Research & Development
University of the Free State
P.O.Box 339
Bloemfontein
South Africa
9300
Tel +27 (0) 51 401 2181
Fax +27 (0) 51 4480370
Cell 0832932890
e-mail: arvconference.hum@mail.uovs.ac.za

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept